Evidence map›Paper›PMID 37953830›Full record

Article3 Biotech2023

Improvement of bacterial blight resistance of the high yielding, fine-grain, rice variety, Gangavati sona through marker-assisted backcross breeding.

C A Manoj, B Muralidhara, P S Basavaraj, M Honnappa, V Ajitha, D Aleena, V G Ishwaryalakshmi, G Usha, C Gireesh, P Senguttuvel and 13 more

Abstract read
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

C A Manoj *University of Agricultural Sciences, Raichur, India.
B MuralidharaUniversity of Agricultural Sciences, Raichur, India.
P S BasavarajICAR-Indian Institute of Rice Research, Hyderabad, India.
M HonnappaUniversity of Agricultural Sciences, Raichur, India.
V AjithaICAR-Indian Institute of Rice Research, Hyderabad, India.
D AleenaICAR-Indian Institute of Rice Research, Hyderabad, India.
V G IshwaryalakshmiICAR-Indian Institute of Rice Research, Hyderabad, India.
G UshaICAR-Indian Institute of Rice Research, Hyderabad, India.
C GireeshICAR-Indian Institute of Rice Research, Hyderabad, India.
P SenguttuvelICAR-Indian Institute of Rice Research, Hyderabad, India.
K B KemparajuICAR-Indian Institute of Rice Research, Hyderabad, India.
L V Subba RaoICAR-Indian Institute of Rice Research, Hyderabad, India.
K BasavarajICAR-Indian Institute of Rice Research, Hyderabad, India.
G S LahaICAR-Indian Institute of Rice Research, Hyderabad, India.
R M SundaramICAR-Indian Institute of Rice Research, Hyderabad, India.
RMahender KumarICAR-Indian Institute of Rice Research, Hyderabad, India.
Santosha RathodICAR-Indian Institute of Rice Research, Hyderabad, India.
P M SalimathUniversity of Agricultural Sciences, Raichur, India.
R LokeshaUniversity of Agricultural Sciences, Raichur, India.
Jayateertha DiwanUniversity of Agricultural Sciences, Raichur, India.
Jayaprakash Mohan NidagundiUniversity of Agricultural Sciences, Raichur, India.
M GowrisankarAnnamalai University, Chidambaram, Tamil Nadu India.
M S Anantha *ICAR-Indian Institute of Rice Research, Hyderabad, India.ORCID 0000-0001-8511-9139

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gangavati sona (GS) is a high-yielding, fine-grain rice variety widely grown in the Tungabhadra command area in Karnataka, India; however, it is susceptible to bacterial blight (BB). Therefore, the present study was conducted to improve the GS variety for BB resistance. Three BB-resistant genes (

Indexed as

BackcrossingBacterial blightDiseaseGenomicsMarkersRice

Identifiers

PMID37953830
PMCPMC10638137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.